Michael A. Garratt - Feb 11, 2022 Form 4 Insider Report for AVIENT CORP (AVNT)

Role
SVP, President CAI - EMEA
Signature
/s/ Lisa K. Kunkle, Power of Attorney For: Michael A Garratt
Stock symbol
AVNT
Transactions as of
Feb 11, 2022
Transactions value $
-$139,285
Form type
4
Date filed
2/15/2022, 04:16 PM
Previous filing
Jun 3, 2021
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNT Common Stock Options Exercise +5.8K +30.83% 24.6K Feb 11, 2022 Direct F1, F2
transaction AVNT Common Stock Tax liability -$139K -2.65K -10.75% $52.64 22K Feb 11, 2022 Direct F3
holding AVNT Common Stock 14.3K Feb 11, 2022 Supplemental Plan F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVNT Restricted Stock Units Options Exercise -5.8K -100% 0 Feb 11, 2022 Common Stock 5.8K Direct F1
transaction AVNT Restricted Stock Units Award $0 +4.55K $0.00 4.55K Feb 14, 2022 Common Stock 4.55K Direct F1
transaction AVNT Stock Appreciation Rights Award $0 +16K $0.00 16K Feb 14, 2022 Common Stock 16K $52.64 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Avient common stock.
F2 Includes dividend equivalents earned with respect to the vested restricted stock units.
F3 Represents shares of Avient common stock that were withheld solely to satisfy the tax withholding obligation applicable to the vesting of restricted stock units on February 11, 2022.
F4 The information in this report is based on a plan statement as of February 11, 2022.
F5 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years.